fenofibrate

非诺贝特

常用释义

词性释义

n.

非诺贝特
例句
  • 全部
  • 非诺贝特
The study found virtually no difference in the risk for amputations above the ankle between those who did and did not take fenofibrate.
研究发现踝以上截肢风险在服用非诺贝特组和非服用非诺贝特组之间并无显著差异。
The risk of a first amputation was 36 percent lower among people taking fenofibrate than those taking the placebo.
初次截肢的风险非诺贝特组较安慰剂组降低了36%。
与高糖组比较非诺贝特干预后能完全或部分逆转上述变化。
目的:探讨非诺贝特对糖尿病肾病的保护机制。
在ACCORD脂质研究基金会,非诺贝特同时降低了微观及宏观尿蛋白量,二者都是胰岛肾病的标志。
但是对照处方Tricor?tablets及微粉化药物分散系统于水中的溶离则受到限制。
疗效是通过将非诺贝特加入辛伐他汀里取得的。
非诺贝特对溶血卵磷脂诱导的血管内皮细胞增生及凋亡的影响
非诺贝特微丸缓释胶囊与辛伐他汀治疗混合型高脂血症的比较
非诺贝特部分阻断氧化型低密度脂蛋白诱导的人单核细胞源树突状细胞的免疫成熟
非诺贝特上调血管内皮细胞一氧化氮合酶的表达
非诺贝特对脂肪组织凝血和纤溶因子表达的影响
Upper gastrointestinal hemorrhage associated with concomitant use of warfarin, losartan potassium, fenofibrate and allopurinol
华法林与氯沙坦、非诺贝特及别嘌醇伍用致上消化道出血
非诺贝特抑制脂肪细胞组织因子表达
吡格列酮和非诺贝特对SD大鼠体脂分布及能量代谢的调节作用
非诺贝特和罗格列酮对大鼠血脂、体重和胰岛素敏感性的作用比较
Effect of Polymorphism of Human Intestinal Fatty Acid Binding Protein Gene on the Therapeutic Efficacy of Fenofibrate
小肠脂肪酸结合蛋白基因多态性对非诺贝特降血脂作用的影响
综述非诺贝特在初期血脂障碍、代谢综合症和2型糖尿病中的应用
非诺贝特对冠状动脉损伤后血管重构的抑制效果
辛伐他汀联合非诺贝特治疗2型糖尿病并混合性高脂血症的疗效和安全性观察
1·Objective To investigate the effects of fenofibrate on E-selectin and intercellular adhesion molecule-1 (ICAM-1) secretion of the endothelial cells.
目的研究非诺贝特对内皮细胞产生E-选择素和细胞间黏附分子1(ICAM-1)的影响。
2·Objective: To investigate the effect of fenofibrate on the expression of adiponectin gene, the level of the plasma adiponectin and endothelial function in diabetic rats.
目的:观察非诺贝特对糖尿病大鼠血脂联素和脂联素基因的表达及内皮细胞功能的干预作用。
3·The study also found that people in the fenofibrate group had a 47 percent lower risk of amputations below the ankle and without large-vessel disease in the amputated limb.
研究还发现非诺贝特组踝以下截肢风险降低47%,所截肢内无大血管病变。
4·The risk of a first amputation was 36 percent lower among people taking fenofibrate than those taking the placebo.
初次截肢的风险非诺贝特组较安慰剂组降低了36%。
5·Conclusion: Fenofibrate can inhibit high glucose-induced proliferation of mesangial cells, decrease synthesis of extracellular matrix, and increase degradation of extracellular matrix.
结论:非诺贝特能抑制高糖培养的系膜细胞增殖,减少胞外基质合成,增加胞外基质的降解。